O122 Prevalence of drug interactions between antiretroviral and co-administered drugs at the Moi teaching and referral hospital (Ampath), Eldoret, Kenya

doi:10.1186/1758-2652-11-S1-O7

Journal of the International AIDS Society

Volume 11
Suppl 1

Viewing options:

Abstract
Full text
PDF (133KB)

Related literature:

Articles citing this article
on Google Scholar
Other articles by authors
on Google Scholar

Kigen GK
Kimaiyo S
Back DJ
Gibbons SE
Sang E
Edwards IG
Owen A
Khoo SH

on PubMed

Kigen GK
Kimaiyo S
Back DJ
Gibbons SE
Sang E
Edwards IG
Owen A
Khoo SH
Related articles/pages
on Google

on Google Scholar

Tools:

Post to:

This article is part of the supplement: Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection .

Oral presentation

O122 Prevalence of drug interactions between antiretroviral and co-administered drugs at the Moi teaching and referral hospital (Ampath), Eldoret, Kenya

GK Kigen¹, S Kimaiyo², DJ Back¹, SE Gibbons¹, E Sang², IG Edwards¹, A Owen¹ and SH Khoo¹

¹University of Liverpool, Department of Pharmacology and Therapeutics, Liverpool, UK

²Moi University School of Medicine, AMPATH, Eldoret, Kenya

corresponding author email

from Ninth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 9–13 November 2008

Journal of the International AIDS Society 2008, 11(Suppl 1):O7doi:10.1186/1758-2652-11-S1-O7


Published:	10 November 2008

First paragraph (this article has no abstract)

Studies in developed countries have shown that drug interactions (DI) involving antiretroviral therapy (ARV) are frequent and under-recognized. No similar work has been carried out in developing countries, where use of fixed dose combinations (FDCs) limits the scope for dose modification.